Shivangi Mohta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shivangi Mohta has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Anita Adib
The James Cancer Hospital Solove Research Institute, The Ohio State University, Columbus, OH 43210, USA
1 shared publication - Lucia Casadei
The Ohio State University Comprehensive Cancer Center Columbus Ohio USA
1 shared publication - Raphael Etomar Pollock
Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, 460 W 10th Ave, Columbus, OH 43210, USA
1 shared publication - Ruhi Sahu
The James Cancer Hospital Solove Research Institute, The Ohio State University, Columbus, OH 43210, USA
1 shared publication
Latest Publications
- Open Access
Cancer-Derived Extracellular Vesicles: Their Role in Sarcoma
Soft tissue sarcomas (STS) are rare malignancies with limited responses to anticancer therapy. Extracellular vesicles (EVs) are a heterogeneous group of bi-lipid layer sacs secreted by cells into extracellular space. Investigations of tumor-derived EVs have revealed their functional capabilities, including cell-to-cell communication and their impact on tumorigenesis, progression, and metastasis; however information on the roles of EVs in sarcoma is currently limited. In this review we investigate the role of various EV cargos in sarcoma and the mechanisms by which those cargos can affect the recipient cell phenotype and the aggressivity of the tumor itself. The study of EVs in sarcoma may help establish novel therapeutic approaches that target specific sarcoma subtypes or biologies, thereby improving sarcoma therapeutics in the future.
Open AccessCancer-Derived Extracellular Vesicles: Their Role in Sarcoma
Soft tissue sarcomas (STS) are rare malignancies with limited responses to anticancer therapy. Extracellular vesicles (EVs) are a heterogeneous group of bi-lipid layer sacs secreted by cells into extracellular space. Investigations of tumor-derived EVs have revealed their functional capabilities, including cell-to-cell communication and their impact on tumorigenesis, progression, and metastasis; however information on the roles of EVs in sarcoma is currently limited. In this review we investigate the role of various EV cargos in sarcoma and the mechanisms by which those cargos can affect the recipient cell phenotype and the aggressivity of the tumor itself. The study of EVs in sarcoma may help establish novel therapeutic approaches that target specific sarcoma subtypes or biologies, thereby improving sarcoma therapeutics in the future.